Capital Flow Monitor · Sponsors · CIK 1853816
Dermata Therapeutics, Inc.
3525 DEL MAR HEIGHTS RD., SAN DIEGO, CA, 92130 · 858-223-0882
Biotechnology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$4.1M
Sold
$4.1M
% sold
100.0%
Investors
14
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-01-07 | D ·current | 506(b) | $4.1M | $4.1M | 100.0% | 14 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Gerald Proehl — Executive Officer / Director, SAN DIEGO, CA
- Kyri K. Van Hoose — Executive Officer, SAN DIEGO, CA
- Christopher J. Nardo — Executive Officer, SAN DIEGO, CA
- Maria Bedoya Toro Munera — Executive Officer, SAN DIEGO, CA
- David Hale — Director, SAN DIEGO, CA
- Wendell Wierenga — Director, SAN DIEGO, CA
- Andrew Sandler — Director, SAN DIEGO, CA
- Brittany Bradrick — Director, SAN DIEGO, CA
- Kathleen Scott — Director, SAN DIEGO, CA
- Mary Fisher — Director, SAN DIEGO, CA
- Steven J. Mento — Director, SAN DIEGO, CA
Placement agents
- H.c. Wainwright & Co., Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.